Medi-Ject's needle-free injector goes OTC (over the counter):
This article was originally published in Clinica
The FDA has given Minneapolis-based Medi-Ject the go-ahead to sell its Medi-Jector Choice needle-free insulin injector over the counter. For the past 20 years, the product has been available on prescription. It uses pressure to form a micro-thin column of insulin which is capable of penetrating the skin and dispersing in the fatty tissue within half a second.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.